메뉴 건너뛰기




Volumn 105, Issue 4, 2011, Pages 688-695

A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor

Author keywords

Coagulation factors; Factor VIII inhibitors; Haemophilia A B; Haemophilia therapy

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR; DRUG METABOLITE; NN 1731; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN; UNCLASSIFIED DRUG;

EID: 79955429941     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-08-0542     Document Type: Article
Times cited : (25)

References (38)
  • 1
    • 77449091890 scopus 로고    scopus 로고
    • Inhibitors in hemophilia A: Advances in elucidation of inhibitory mechanisms and in inhibitor management with bypassing agents
    • Ananyeva NM, Lee TK, Jain N, et al. Inhibitors in hemophilia A: advances in elucidation of inhibitory mechanisms and in inhibitor management with bypassing agents. Semin Thromb Hemost 2009; 35: 735-751.
    • (2009) Semin Thromb Hemost , vol.35 , pp. 735-751
    • Ananyeva, N.M.1    Lee, T.K.2    Jain, N.3
  • 2
    • 77955034768 scopus 로고    scopus 로고
    • New developments in laboratory diagnosis and monitoring
    • Kitchen S, Hayward C, Negrier C, et al. New developments in laboratory diagnosis and monitoring. Haemophilia 2010;16 (Suppl 5): 61-66.
    • (2010) Haemophilia , vol.16 , Issue.SUPPL. 5 , pp. 61-66
    • Kitchen, S.1    Hayward, C.2    Negrier, C.3
  • 3
    • 75749152988 scopus 로고    scopus 로고
    • Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recomtrial
    • Kenet G, Stenmo CB, Blemings A, et al. Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recomtrial. Thromb Haemost 2010; 103: 351-359.
    • (2010) Thromb Haemost , vol.103 , pp. 351-359
    • Kenet, G.1    Stenmo, C.B.2    Blemings, A.3
  • 4
    • 77955015786 scopus 로고    scopus 로고
    • Tests of global haemostasis and their applications in bleeding disorders
    • Nair SC, Dargaud Y, Chitlur M, et al. Tests of global haemostasis and their applications in bleeding disorders. Haemophilia 2010; 16 (Suppl 5): 85-92.
    • (2010) Haemophilia , vol.16 , Issue.SUPPL. 5 , pp. 85-92
    • Nair, S.C.1    Dargaud, Y.2    Chitlur, M.3
  • 5
    • 10744231994 scopus 로고    scopus 로고
    • Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay
    • Turecek PL, Varadi K, Keil B, et al. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb 2003; 33: 16-22.
    • (2003) Pathophysiol Haemost Thromb , vol.33 , pp. 16-22
    • Turecek, P.L.1    Varadi, K.2    Keil, B.3
  • 6
    • 24644460532 scopus 로고    scopus 로고
    • Major surgery in a severe haemophilia A patient with high titre inhibitor: Use of the thrombin generation test in the therapeutic decision
    • Dargaud Y. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision. Haemophilia 2005; 11: 552-558.
    • (2005) Haemophilia , vol.11 , pp. 552-558
    • Dargaud, Y.1
  • 7
    • 48949087350 scopus 로고    scopus 로고
    • Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro
    • Gatt A, van Veen JJ, Woolley AM, et al. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.Thromb Haemost 2008; 100: 350-355.
    • (2008) Thromb Haemost , vol.100 , pp. 350-355
    • Gatt, A.1    van Veen, J.J.2    Woolley, A.M.3
  • 8
    • 0242401773 scopus 로고    scopus 로고
    • Calibrated automated thrombin generation measurement in clotting plasma
    • Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
    • (2003) Pathophysiol Haemost Thromb , vol.33 , pp. 4-15
    • Hemker, H.C.1    Giesen, P.2    Al, D.R.3
  • 9
    • 15344343052 scopus 로고    scopus 로고
    • Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B
    • Dargaud Y, Beguin S, Lienhart A, et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005; 93: 475-480.
    • (2005) Thromb Haemost , vol.93 , pp. 475-480
    • Dargaud, Y.1    Beguin, S.2    Lienhart, A.3
  • 10
    • 0036797888 scopus 로고    scopus 로고
    • The thrombogram in rare inherited coagulation disorders: Its relation to clinical bleeding
    • Al Dieri R, Peyvandi F, Santagostino E, et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002; 88: 576-582.
    • (2002) Thromb Haemost , vol.88 , pp. 576-582
    • Al, D.R.1    Peyvandi, F.2    Santagostino, E.3
  • 11
    • 50049135947 scopus 로고    scopus 로고
    • Thrombin generation testing in routine clinical practice: Are we there yet?
    • Van Veen JJ, Gatt A, Makris M. Thrombin generation testing in routine clinical practice: are we there yet? Br J Haematol 2008; 142: 889-903.
    • (2008) Br J Haematol , vol.142 , pp. 889-903
    • van Veen, J.J.1    Gatt, A.2    Makris, M.3
  • 12
    • 44649193756 scopus 로고    scopus 로고
    • Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VII
    • Dargaud Y, Bordet JC, Lienhart A, et al. Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VII. Semin Hematol 2008; 45 (Suppl 1): S72-73.
    • (2008) Semin Hematol , vol.45 , Issue.SUPPL. 1
    • Dargaud, Y.1    Bordet, J.C.2    Lienhart, A.3
  • 13
    • 78049287333 scopus 로고    scopus 로고
    • External quality assessment for thrombin generation tests: An exploration
    • Kluft C, Meijer P. External quality assessment for thrombin generation tests: an exploration. Semin Thromb Hemost. 2010; 36: 791-796
    • (2010) Semin Thromb Hemost , vol.36 , pp. 791-796
    • Kluft, C.1    Meijer, P.2
  • 14
    • 43749099671 scopus 로고    scopus 로고
    • Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma
    • Duchemin J, Pan-Petesch B, Arnaud B, et al. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 2008; 99: 767-773.
    • (2008) Thromb Haemost , vol.99 , pp. 767-773
    • Duchemin, J.1    Pan-Petesch, B.2    Arnaud, B.3
  • 15
    • 61349201697 scopus 로고    scopus 로고
    • The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents
    • van Veen JJ, Gatt A, Bowyer AE, et al. The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents. Int J Lab Hematol 2009; 31: 189-198.
    • (2009) Int J Lab Hematol , vol.31 , pp. 189-198
    • van Veen, J.J.1    Gatt, A.2    Bowyer, A.E.3
  • 16
    • 0034970007 scopus 로고    scopus 로고
    • The role of factor XI in thrombin generation induced by low concentrations of tissue factor
    • Keularts IM, Zivelin A, Seligsohn U, et al. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 2001; 85: 1060-1065.
    • (2001) Thromb Haemost , vol.85 , pp. 1060-1065
    • Keularts, I.M.1    Zivelin, A.2    Seligsohn, U.3
  • 17
    • 33644858358 scopus 로고    scopus 로고
    • Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX, or XI
    • Livnat T, Zivelin A, Martinowitz U, et al. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX, or XI. J Thromb Hemost 2006; 4: 192-200.
    • (2006) J Thromb Hemost , vol.4 , pp. 192-200
    • Livnat, T.1    Zivelin, A.2    Martinowitz, U.3
  • 18
    • 70449381348 scopus 로고    scopus 로고
    • Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies
    • Livnat T, Tamarin I, Mor Y, et al. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies. Thromb Haemost 2009; 102: 487-492.
    • (2009) Thromb Haemost , vol.102 , pp. 487-492
    • Livnat, T.1    Tamarin, I.2    Mor, Y.3
  • 19
    • 41849145377 scopus 로고    scopus 로고
    • Corn trypsin inhibitor in fluorogenic throm- bin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters
    • van Veen JJ, Gatt A, Cooper PC, et al. Corn trypsin inhibitor in fluorogenic throm- bin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolysis 2008; 19: 183-189.
    • (2008) Blood Coagul Fibrinolysis , vol.19 , pp. 183-189
    • van Veen, J.J.1    Gatt, A.2    Cooper, P.C.3
  • 20
    • 13244264708 scopus 로고    scopus 로고
    • Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition
    • Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2: 1954-1959.
    • (2004) J Thromb Haemost , vol.2 , pp. 1954-1959
    • Luddington, R.1    Baglin, T.2
  • 21
    • 34848862747 scopus 로고    scopus 로고
    • Effect of standardization and normaliz ation on imprecision of calibrated automated thrombography: An international multicentre study
    • Dargaud Y, Luddington R, Gray E, et al. Effect of standardization and normaliz ation on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol 2007; 139: 303-309.
    • (2007) Br J Haematol , vol.139 , pp. 303-309
    • Dargaud, Y.1    Luddington, R.2    Gray, E.3
  • 22
    • 67049119829 scopus 로고    scopus 로고
    • Monitoring thrombin generation: Is addition of corn trypsin inhibitor needed?
    • Spronk HM, Dielis AW, Panova-Noeva M, et al. Monitoring thrombin generation: is addition of corn trypsin inhibitor needed? Thromb Haemost 2009; 101: 1156-1162.
    • (2009) Thromb Haemost , vol.101 , pp. 1156-1162
    • Spronk, H.M.1    Dielis, A.W.2    Panova-Noeva, M.3
  • 23
    • 79951933686 scopus 로고    scopus 로고
    • First 20 years with recombinant FVIIa (NovoSeven)
    • Hedner U, Lee CA. First 20 years with recombinant FVIIa (NovoSeven). Haemophilia 2011; 17: e172-182.
    • (2011) Haemophilia , vol.17
    • Hedner, U.1    Lee, C.A.2
  • 24
    • 54949106943 scopus 로고    scopus 로고
    • Factor VIIa and its potential therapeutic use in bleeding-associated pathologies
    • Hedner U. Factor VIIa and its potential therapeutic use in bleeding-associated pathologies. Thromb Haemost 2008; 100: 557-562.
    • (2008) Thromb Haemost , vol.100 , pp. 557-562
    • Hedner, U.1
  • 25
    • 69949102958 scopus 로고    scopus 로고
    • Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors
    • Kenet G, Lubetsky A, Luboshitz J, et al. Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors. Haemophilia 2009; 15: 1065-1073.
    • (2009) Haemophilia , vol.15 , pp. 1065-1073
    • Kenet, G.1    Lubetsky, A.2    Luboshitz, J.3
  • 26
    • 0037231876 scopus 로고    scopus 로고
    • Influence of factor VIIa and phos pholipids on coagulation in ''acquired hemophilia
    • Butenas S, Brummel KE, Paradis SG, et al. Influence of factor VIIa and phos pholipids on coagulation in ''acquired hemophilia. Arterioscler Thromb Vasc Biol 2003; 23: 123-129.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 123-129
    • Butenas, S.1    Brummel, K.E.2    Paradis, S.G.3
  • 27
    • 57149090766 scopus 로고    scopus 로고
    • Mechanisms of action of rec ombinant activated factor VII in the context of tissue factor concentration and distribution
    • Ovanesov MV, Panteleev MA, Sinauridze EI, et al. Mechanisms of action of rec ombinant activated factor VII in the context of tissue factor concentration and distribution. Blood Coagul Fibrinolysis 2008; 19: 743-755.
    • (2008) Blood Coagul Fibrinolysis , vol.19 , pp. 743-755
    • Ovanesov, M.V.1    Panteleev, M.A.2    Sinauridze, E.I.3
  • 28
    • 68149103290 scopus 로고    scopus 로고
    • Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa
    • Eichinger S, Lubsczyk B, Kollars M, et al. Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa. Eur J Clin Invest 2009; 39: 707-713.
    • (2009) Eur J Clin Invest , vol.39 , pp. 707-713
    • Eichinger, S.1    Lubsczyk, B.2    Kollars, M.3
  • 29
    • 4043184093 scopus 로고    scopus 로고
    • Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A
    • Villar A, Aronis S, Morfini M, et al. Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A. Haemophilia 2004; 10: 352-359.
    • (2004) Haemophilia , vol.10 , pp. 352-359
    • Villar, A.1    Aronis, S.2    Morfini, M.3
  • 30
    • 67649868161 scopus 로고    scopus 로고
    • Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors
    • Martinowitz U, Livnat T, Zivelin A, et al. Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors. Haemophilia 2009; 15: 904-910.
    • (2009) Haemophilia , vol.15 , pp. 904-910
    • Martinowitz, U.1    Livnat, T.2    Zivelin, A.3
  • 31
    • 47649108640 scopus 로고    scopus 로고
    • Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma
    • Livnat T, Martinowitz U, Zivelin A, et al. Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma. Haemophilia 2008; 14: 782-786.
    • (2008) Haemophilia , vol.14 , pp. 782-786
    • Livnat, T.1    Martinowitz, U.2    Zivelin, A.3
  • 32
    • 0035923721 scopus 로고    scopus 로고
    • Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity
    • USA
    • Persson E, Kjalke M, Olsen OH, et al. Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity. Proc Natl Acad Sci USA 2001; 98: 13583-13588.
    • (2001) Proc Natl Acad Sci , vol.98 , pp. 13583-13588
    • Persson, E.1    Kjalke, M.2    Olsen, O.H.3
  • 33
    • 33847054740 scopus 로고    scopus 로고
    • A Variant of recombinant factor VIIa with enhanced Procoagulant and antifibrinolytic activities in an in vitro model of hemophilia
    • Allen GA, Persson E, Campbell A, et al. A Variant of recombinant factor VIIa with enhanced Procoagulant and antifibrinolytic activities in an in vitro model of hemophilia. Artherioscler Thromb Vasc Biol 2007; 27: 683-689.
    • (2007) Artherioscler Thromb Vasc Biol , vol.27 , pp. 683-689
    • Allen, G.A.1    Persson, E.2    Campbell, A.3
  • 34
    • 34548317168 scopus 로고    scopus 로고
    • Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients
    • Brophy DF, Martin EJ, Nolte ME, et al. Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients. Haemophilia 2007; 13: 533-541.
    • (2007) Haemophilia , vol.13 , pp. 533-541
    • Brophy, D.F.1    Martin, E.J.2    Nolte, M.E.3
  • 35
    • 0242494903 scopus 로고    scopus 로고
    • Improved hemostasis with super- active analogs of factor VIIa in a mouse model of hemophilia A
    • Tranholm M, Kristensen K, Kristensen AT, et al. Improved hemostasis with super- active analogs of factor VIIa in a mouse model of hemophilia A. Blood 2003; 102: 3615-3620.
    • (2003) Blood , vol.102 , pp. 3615-3620
    • Tranholm, M.1    Kristensen, K.2    Kristensen, A.T.3
  • 36
    • 57449094975 scopus 로고    scopus 로고
    • Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue
    • Larsen OH, Clausen N, Persson E, et al. Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue. Br J Haematol 2009; 144: 99-106.
    • (2009) Br J Haematol , vol.144 , pp. 99-106
    • Larsen, O.H.1    Clausen, N.2    Persson, E.3
  • 37
    • 70449555316 scopus 로고    scopus 로고
    • Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions
    • Aljamali MN, Kjalke M, Hedner U, et al. Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions. Haemophilia 2009; 15: 1318-1326.
    • (2009) Haemophilia , vol.15 , pp. 1318-1326
    • Aljamali, M.N.1    Kjalke, M.2    Hedner, U.3
  • 38
    • 59049098711 scopus 로고    scopus 로고
    • Evaluation of the safety and pharmacokinetics of a fastacting recombinant FVIIa analogue, NN1731, in healthy male subjects
    • Møss J, Scharling B, Ezban M, et al. Evaluation of the safety and pharmacokinetics of a fastacting recombinant FVIIa analogue, NN1731, in healthy male subjects. J Thromb Haemost 2009; 7: 299-305.
    • (2009) J Thromb Haemost , vol.7 , pp. 299-305
    • Møss, J.1    Scharling, B.2    Ezban, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.